Catheter Precision Q1 revenue up 200% to $432K; net loss cut to $1.7M; Flyte acquisition adds aviation revenue

Catheter Precision, Inc.

Q1 revenue $432K (200% YoY) driven by medical device segment (+73%) and new Flyte aviation platform.
Net loss narrowed to $1.7M from $4.0M in Q1 2025; includes ~$560K non-cash charges.
Flyte acquisition generated $200K monthly revenue run rate within 22 days; fleet expanding to 5 jets by end of Q2 2026.
Medical device products in 15 countries; new clinical data on VIVO and LockeT presented at HRS congress.
Company now a dual-engine growth platform combining medical devices and aviation infrastructure.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Catheter Precision, Inc. reported financial results for first quarter of 2026.

Period: first quarter of 2026
Result: reported results

Exact text from the filing

On May 18, 2026, Catheter Precision, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2026.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Catheter Precision, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-017612

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.